...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Epidarex Capital Creates Nodthera Limited
07/28/16
> ARTES and Burnet Institute Join Forces to Develop Novel Hepatitis C Vaccine
07/26/16
> FDA Grants QIDP and Fast Track Designations to MCB3837, Morphochem’s Novel Intravenous Antibacterial to Treat C. Difficile Infections
07/25/16
> RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection
07/21/16
> Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
07/20/16
> HYD Pharma Receives Ethical Approval for Phase 2 Clinical Trial Investigating the Anticancer Effect of Deuterium Depletion in CLL
07/18/16
> Vetter Provides Insights into Its Long-Term Expansion Plans That Include the Purchasing of Property in the City of Des Plaines
07/15/16
> RedHill Biopharma Announces Research Collaboration with NIH for Potential Ebola Treatment
07/13/16
> Study Confirms Analytical Precision Of MammaTyper® In Molecular Breast Cancer Typing
07/12/16
> International Collaboration to Create New Cancer Models to Accelerate Research
07/11/16
> Australian Drug Discovery Company AdAlta, Announces IPO to Accelerate New Therapies for Lung Fibrosis
07/08/16
> Claristep® Filtration System: Fast, Easy and Reliable Sample Preparation
07/07/16
> Sartorius Stedim BioOutsource Introduces New Released N-Glycan Assay
07/07/16
> RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT™ for Migraines with Grupo JUSTE in Spain and Additional Potential Territories
07/06/16
> Atriva Therapeutics Completes Transfer of Co-Infection Patent
07/05/16
> SomantiX, PharmBioTec and Pharmacelsus Receive €1.5M EUROSTARS Grant for the Small Molecule Preclinical Development Program
06/30/16
> Zytoprotec Completes Enrollment in Phase II Study With Novel Peritoneal Dialysis Fluid
06/30/16
> First-In-Human Study of Immbio’s Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
06/30/16
> BoneAlbumin™ Induces Better Bone Formation
06/29/16
> Avita Medical Awarded USD 7.96m in BARDA Extension Deal
06/27/16
> RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn’s Disease Associated with MAP Infection
06/23/16
> Morphochem’s Investigational New Drug (IND) Application Accepted by the FDA – Novel Antibacterial for Intravenous Treatment of Clostridium difficile Infections (CDI), MCB3837/MCB3681, Can Now Move into Phase 2
06/22/16
> RedHill Biopharma Announces Positive Final Results with Primary and Secondary Endpoints Met in Phase 1 Study with YELIVA™ in Advanced Solid Tumors
06/22/16
> RedHill Biopharma Announces First Patients Dosed in Phase II Study with BEKINDA™ for IBS-D
06/21/16
> Polyganics Announces CE Mark for NEUROCAP®, the Nerve Capping Device for Treatment and Prevention of Symptomatic Neuroma
06/21/16
> TVM Life Science Ventures VII Announces Investment in Mediti Pharma Inc. for the Development of a Novel Treatment for Alzheimer's Disease Psychosis
06/20/16
> Molecular Breast Cancer Subtyping: Study Confirms Advantages of the In Vitro Diagnostic Test Kit Mammatyper® over Immunohistochemistry (IHC)
06/16/16
> Jörn Aldag Appointed CEO of Hookipa Biotech
06/16/16
> TROD Medical’s Prostate Focal Therapy Device Encage™ Advances in US and UK Clinical Studies
06/16/16
> Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System
06/15/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 43